RCM Insider Trading Activity and SEC Form 4 Filings
RCM insider trading summary
No open-market insider purchases or sales of R1 RCM Inc. (RCM) have been reported on SEC Form 4 in the past 12 months.
Latest RCM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 19, 2024 | TI IV ACHI Holdings, LP | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | Tcp-Asc Gp, LLC | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | Karim Saddi | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | TowerBrook Investors, Ltd. | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | ACHI Series LLLP TCP-ASC | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | TI IV ACHI Holdings GP, LLC | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | Health Alliance Ascension | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | Jonathan Bilzin | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Nov 19, 2024 | Neal Moszkowski | Director | Sell | $436.3M (30,548,388 @ $14.28) |
| Mar 7, 2024 | John M. Sparby | President | Sell | $144K (10,046 @ $14.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.